Urology Surgical Instruments Market Overview Analysis By Fortune Business Insights Analysis
Market Summary
According to Fortune Business Insights: The global urology surgical instruments market size was valued at USD 14.09 billion in 2025. The market is projected to grow from USD 15.19 billion in 2026 to USD 27.59 billion by 2034, exhibiting a CAGR of 7.75% during the forecast period. Growth is attributed to rising urological conditions, minimally invasive procedures enabled by new technologies, and better healthcare facilities. American Hospital Association's figure of 4,700 U.S. hospitals with urology departments in 2023.
Key Market Trends
Robotic surgery and modern imaging are reducing tissue damage in minimally invasive procedures. AI and machine learning are being built into urology instruments to improve surgical precision. Manufacturers are also adopting hybrid manufacturing facilities for flexibility, lower costs, and sustainability.
Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/112768
Key Market Drivers
Demand from patients with kidney stones, urinary incontinence, and prostate cancer is the core driver. Technological advances in robotics and imaging add to growth, as does a growing geriatric population with more urological problems. Higher healthcare investment in emerging economies further supports demand.
Market Restraints
The high cost of advanced instruments limits use in cost-sensitive markets. Strict medical device regulations delay product approvals, and a shortage of skilled professionals trained on advanced tools slows adoption.
Segmentation Analysis
By product, the market covers envision systems, endoscopes, peripheral systems, and consumables and accessories. Envision systems include endoscopic cameras, camera heads, light sources, and monitors and displays. Endoscopes include nephoscopes, cystoscopes, and ureteroscopes. Peripheral systems include insufflators and endoscopic fluid management systems. By application, the market spans prostate procedures, vasectomy, ureteroscopy, incontinence procedures, and kidney reconstruction, with prostate procedures described as the most significant. By end user, hospitals and clinics hold a significant share, while ambulatory surgical centers are growing with outpatient demand.
Regional Outlook
North America is driven by automation in urology and new product launches by major players.
Europe is described as leading, citing strong device manufacturers, minimally invasive surgery use, and government support, although that statement appears to refer to the broader medical device market rather than urology instruments specifically.
Asia Pacific is expected to grow rapidly, driven by India and China.
Latin America and the Middle East and Africa are covered in the report's scope without further detail.
Connect with Our Expert for any Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/112768
Competitive Landscape
Key players include Medtronic, Teleflex Incorporated, Cook, KARL STORZ GmbH & Co. KG, Stryker, Boston Scientific Corporation, Richard WOLF GmbH, Coloplast Corp, Olympus Corporation, and CooperSurgical, Inc.
In August 2024, KARL STORZ acquired Ascensus Surgical to add robotic surgery solutions to its Performance-Guided Surgery offering.
In May 2024, Olympus introduced a new ureteroscope intended to improve patient outcomes.
Curious About Japan’s Market? Explore the Latest Urology Surgical Instruments Market Insights